Cliff Asness's AUPH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 481,336 shares of Aurinia Pharmaceuticals Inc. (AUPH) worth $7.68 M, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AUPH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 366,077 shares. Largest reduction occurred in Q2 2025, reducing 288,893 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Aurinia Pharmaceuticals (AUPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aurinia Pharmaceuticals (AUPH) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +123,044 | Add 34.34% | 481,336 | $15.95 |
| Q3 2025 | +143,642 | Add 66.92% | 358,292 | $11.05 |
| Q2 2025 | -288,893 | Reduce 57.37% | 214,650 | $8.47 |
| Q1 2025 | +40,380 | Add 8.72% | 503,543 | $8.04 |
| Q4 2024 | -105,155 | Reduce 18.50% | 463,163 | $8.98 |
| Q3 2024 | +366,077 | Add 181.01% | 568,318 | $7.33 |
| Q2 2024 | +202,241 | New Buy | 202,241 | $5.71 |
| Q1 2024 | -21,435 | Sold Out | 0 | $0.00 |
| Q4 2023 | +2,829 | Add 15.20% | 21,435 | $8.99 |
| Q3 2023 | +7,446 | Add 66.72% | 18,606 | $7.77 |
| Q2 2023 | -12,454 | Reduce 52.74% | 11,160 | $9.68 |
| Q1 2023 | +11,658 | Add 97.51% | 23,614 | $10.96 |
| Q4 2022 | +11,956 | New Buy | 11,956 | $4.32 |
Cliff Asness's Aurinia Pharmaceuticals Investment FAQs
Cliff Asness first purchased Aurinia Pharmaceuticals Inc. (AUPH) in Q4 2022, acquiring 11,956 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Aurinia Pharmaceuticals Inc. (AUPH) for 13 quarters since Q4 2022.
Cliff Asness's largest addition to Aurinia Pharmaceuticals Inc. (AUPH) was in Q3 2024, adding 568,318 shares worth $4.17 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 481,336 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $7.68 M.
As of the Q4 2025 filing, Aurinia Pharmaceuticals Inc. (AUPH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Aurinia Pharmaceuticals Inc. (AUPH) was 568,318 shares, as reported at the end of Q3 2024.